Evidence map›Paper›PMID 30205839›Full record

ArticleGenome biology2018

Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity.

Paul Geeleher, Aritro Nath, Fan Wang, Zhenyu Zhang, Alvaro N Barbeira, Jessica Fessler, Robert L Grossman, Cathal Seoighe, R Stephanie Huang

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Integrative Computational Framework,bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Paul GeeleherSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.
Aritro NathSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Fan WangSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
Zhenyu ZhangCenter for Data Intensive Science, University of Chicago, Chicago, IL, USA.
Alvaro N BarbeiraSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.
Jessica FesslerDepartment of Pathology, University of Chicago, Chicago, IL, USA.
Robert L GrossmanCenter for Data Intensive Science, University of Chicago, Chicago, IL, USA.
Cathal SeoigheSchool of Mathematics, Statistics and Applied Mathematics, National University of Ireland, Galway, Ireland.
R Stephanie HuangSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA. rshuang@umn.edu.
University of Chicago · USUniversity of Minnesota · USOllscoil na Gaillimhe – University of Galway · IE

Funding

Whole GenomeU01GM061393 · NIGMS · UNIVERSITY OF CHICAGO · PI RATAIN, MARK J · 2000 to 2014
$39.0M
Drug repurposing in breast cancerR01CA204856 · NCI · UNIVERSITY OF MINNESOTA · PI HUANG, RONG STEPHANIE · 2018 to 2022
$2.2M
Genome-wide interrogation of genetic signatures for glucocorticoid sensitivityK08GM089941 · NIGMS · UNIVERSITY OF CHICAGO · PI HUANG, RONG STEPHANIE · 2010 to 2014
$498k
Incorporation of microRNA expression in pharmacogenetic prediction modelsR21CA139278 · NCI · UNIVERSITY OF CHICAGO · PI DOLAN, MARY EILEEN, HUANG, RONG STEPHANIE · 2009 to 2010
$378k
Novel computational approaches for pharmacogenomic discoveryK99HG009679 · NHGRI · UNIVERSITY OF CHICAGO · PI GEELEHER, PAUL · 2018 to 2018
$85k
Cancer Research UKNCI NIH HHS R01 CA204856NCI NIH HHS R21 CA139278NHGRI NIH HHS K99 HG009679NIGMS NIH HHS K08 GM089941NIGMS NIH HHS U01 GM061393
6 · The paper itself

Abstract

Expression quantitative trait loci (eQTLs) identified using tumor gene expression data could affect gene expression in cancer cells, tumor-associated normal cells, or both. Here, we have demonstrated a method to identify eQTLs affecting expression in cancer cells by modeling the statistical interaction between genotype and tumor purity. Only one third of breast cancer risk variants, identified as eQTLs from a conventional analysis, could be confidently attributed to cancer cells. The remaining variants could affect cells of the tumor microenvironment, such as immune cells and fibroblasts. Deconvolution of tumor eQTLs will help determine how inherited polymorphisms influence cancer risk, development, and treatment response.

Indexed as

Gene ExpressionModels, StatisticalQuantitative Trait LociBreast NeoplasmsCarcinogenesisComputer SimulationFemaleFibroblastsGenetic VariationGenome-Wide Association StudyGenotypeHumansNeoplasmsTumor MicroenvironmentCancerDeconvolutionExpression quantitative trait locus (eQTL)Gene regulationGenome-wide association study (GWAS)

Identifiers

PMID30205839
PMCPMC6131897
OpenAlexW2891092102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.